EX-23.1 16 exhibit231f-1.htm EXHIBIT 23.1 Exhibit
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Realm Therapeutics plc:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Philadelphia, Pennsylvania
May 22, 2018